The daily trading volume for Acumen Pharmaceuticals (NASDAQ: ABOS) fluctuates dynamically based on overall market liquidity, institutional rebalancing, and recent corporate news or earnings disclosures. While average daily volume hovers around several hundred thousand shares, periods marked by clinical trial updates or scientific conference presentations frequently experience sharp spikes in trading activity as retail and institutional investors react to new data.